Marker Therapeutics Inc (MRKR)

[4fatcat4]

Feel your frustration, most of us do, but can't blame 0007 for cheerleading if he bought in at these share prices. IF he did, he missed all the fun with the Pancreatic disaster that got us here, a fall that had NOTHING to do with the effectiveness of MultiTAA treatments.

From everything I've come across, as long as they continue to succeed,
MultiTAA treatments far outperform CarT in every aspect. From easy delivery to no side effects to MORE effective to far LESS expensive, the upside of MRKR is incredible even to us fools that bought in much higher.